3 - 3 |
Challenges that lie ahead - Comment Lampard G |
4 - 4 |
AZ calls off one drug launch, but opens door to Crestor approval [Anonymous] |
4 - 4 |
BASF gets fighting fit for the future [Anonymous] |
5 - 5 |
10m pound for closer links with industry [Anonymous] |
5 - 5 |
Differential pricing [Anonymous] |
5 - 5 |
Degussa hopes for economic upturn [Anonymous] |
5 - 5 |
Futura plans private placing to raise 3m pound [Anonymous] |
6 - 6 |
BioForce joins forces down under to seek out breast cancer treatment [Anonymous] |
6 - 6 |
Sustiva shows sustained success [Anonymous] |
6 - 6 |
New therapies to boost cancer fight [Anonymous] |
8 - 8 |
UK Lab-plant scales the trade wall in China [Anonymous] |
8 - 8 |
UK Lab-plant scales the trade wall in China [Anonymous] |
11 - 11 |
Awards ensure UK keeps brain-gain [Anonymous] |
11 - 11 |
Formatech and Abbott Laboratories form alliance to expand services ... [Anonymous] |
11 - 11 |
... and Italian Chiesi links up up with UK Vectura [Anonymous] |
12 - 12 |
Lock Inspection leads the weigh [Anonymous] |
12 - 12 |
Europe to reform medicines agency [Anonymous] |
15 - 16 |
Advances in particle science and technology Staniforth J |
18 - 20 |
Developing support in solid-phase chemistry Houlton S |
22 - 23 |
Innovation is the key to Swiss pharma success |
24 - 24 |
Dynamic developments Reutimann H |
25 - 25 |
Treff leads the way [Anonymous] |
31 - 31 |
Integrated lines used to improve efficiency [Anonymous] |
36 - 37 |
Market strategy backs one-pot granulation [Anonymous] |
39 - 40 |
Chemspec goes Dutch [Anonymous] |
41 - 42 |
Manesty's service for the industry |